Paydirt
XFOR
Ticker

X4 Pharmaceuticals, Inc.

XFOR · Healthcare · X4 Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics fo…

X4 Pharmaceuticals, Inc. (XFOR), in the Healthcare sector, has 3 disclosed filings on Paydirt over the trailing twelve months from 2 corporate insiders: 1 purchase and 2 sales. Filers took a median of 1 day from execution to disclosure, and the most recent trade was executed Aug 12 and filed Aug 13. The most active filer was Adam R Craig with 2 filings.

Add to watchlist
Filings, ttm
3
1 buy · 2 sells
Traders, ttm
2
2 insiders
Volume, ttmiDollar value disclosed in the window
$570K
estimated for Congress, as filed for insiders
Median delay
1d
execution to disclosure
Last traded
Aug 12
Filed Aug 13
ADViAverage daily dollar volume
$3.2M
market data
Share price · 12M
$4.21 (+24.6%)
$4.67$3.76$2.86Sep 22 2025Mar 6Aug 18

Adjusted for splits and dividends.

Volume by month
$320K$160K$0Oct 2024Apr 2025Oct 2025Apr 2026Oct 2024 · sells $259KOct 2025 · buys $250KAug 2026 · sells $320K
Buys $250K Sells $579K

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed
AC Adam R Craig Executive Chairman 2 filings AM Adam S. Mostafa Chief Financial Officer 1 filing PR Paula Ragan President and CEO 1 filing JV John Volpone President 1 filing
Recent filings
John VolponeSALE President $109K
24,576 sh × $4.44
Exec Aug 12
Filed Aug 13 · 4:13 PM ET Adam R CraigSALE Executive Chairman $211K
47,436 sh × $4.44
Exec Aug 12
Filed Aug 13 · 4:10 PM ET Adam R CraigPURCHASE Executive Chairman $250K
86,206 sh × $2.90
Exec Oct 23 2025
Filed Oct 27 2025 · 6:40 PM ET Paula RaganSALE President and CEO $132K
239,436 sh × $0.55
Exec Oct 7 2024
Filed Oct 8 2024 · 5:30 PM ET Adam S. MostafaSALE Chief Financial Officer $127K
230,645 sh × $0.55
Exec Oct 7 2024
Filed Oct 8 2024 · 5:30 PM ET